Thesis
Fluorescent gold nanorod probes for the detection of cancer mRNA biomarkers
- Creator
- Rights statement
- Awarding institution
- University of Strathclyde
- Date of award
- 2020
- Thesis identifier
- T15500
- Person Identifier (Local)
- 201557684
- Qualification Level
- Qualification Name
- Department, School or Faculty
- Abstract
- Cancer is a leading cause of death worldwide and high mortality rates are due todiagnosis at advanced disease stages, where the success of treatment is reduced.Current cancer diagnostic techniques rely on anatomical imaging or invasive tumourbiopsies that lack the sensitivity to detect early disease stages. Circulating cancerbiomarkers, including circulating tumour cells and cell free DNAs and RNAs offer theopportunity to non-invasively detect cancer signatures at early disease states.Current investigations into liquid biopsies for the detection of circulating tumourcells and cell free RNAs lack sensitivity, specificity and involve complex sampleprocessing.Therefore, there is a need for an early cancer detection method to improvetreatment success and patient outcomes. As cancer cells display different geneticsfrom healthy cells, genetic biomarkers have become of great interest for cancerdetection. RNA biomarkers are of particular interest, as they can be detected in theserum of cancer patients even at early disease stages. Here, the synthesis offluorescent gold nanorod probes for the detection of cancer mRNA biomarkers inliquid biopsies will be reported.The nanoprobe consists of gold nanorods functionalised with fluorophore labelledhairpin DNA that is targeted against a cancer mRNA biomarker sequence. Due tothe optical properties of gold nanorods, the fluorophore is quenched by energytransfer in the closed hairpin DNA conformation and fluorescence is only generatedupon target mRNA hybridisation. This provides a high signal to background ratio dueto the surface plasmon enhanced energy transfer in the hairpin DNA conformationand surface plasmon enhanced fluorescence following target hybridisation.Steady state and time resolved fluorescence spectroscopy of the nanoprobeincubated with non-target and target DNA has demonstrated the nanoprobebinding specificity. Flow cytometry of cell lines incubated with nanoprobes hasdemonstrated the nanoprobe is capable of specifically detecting target mRNAwithin individual target mRNA expressing cells and the fluorescence of the nanoprobe is proportional to target mRNA expression levels. Nanoprobe uptakeinto cells and target binding specificity in cancer cells has been demonstratedthrough fluorescence confocal microscopy and fluorescence lifetime imagingmicroscopy, with both the fluorescence emission and fluorescence lifetime of thenanoprobe increasing after incubation with target mRNA expressing cells. Liquidbiopsies from cancer patients have also been investigated which demonstrated thepresence of a fluorescence population in cancer positive samples followingnanoprobe incubation, demonstrating the ability of nanoprobes to detectcirculating tumour cells. Furthermore, the ability of nanoprobes to detect targetmRNA in exosomes extracted from cancer cell lines was demonstrated, providingthe potential for nanoprobes to detect cell free circulating mRNAs within liquidbiopsies. These investigations have demonstrates the capability of nanoprobes fordetecting cancer mRNA biomarkers in liquid biopsies and the potential clinicalapplications of nanoprobes in cancer detection.While nanoprobe optimisation was initially focused on one cancer biomarker, CMYC, nanoprobes have been designed against several other mRNA cancerbiomarkers of interest, including HER1, HER2, SOX2, as well as wildtype andmutational P53. Successful synthesis of these nanoprobes show the potential formultiplexed biomarker detection. Molecular sensing and imaging of mRNAbiomarkers demonstrated in this work provides the potential for a sensitive, noninvasive and early cancer detection method from liquid biopsies.
- Advisor / supervisor
- Chen, Yu
- Birch, David
- Resource Type
- Note
- Previously held under moratorium from 31 July 2023 until 27 July 2026.
- DOI
- Date Created
- 2019
- Former identifier
- 9912789292502996
Relations
Items
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
|
PDF of thesis T15500 | 2021-07-02 | Public | Download |